Wrapped up the first edition of ERCA News, a monthly webinar on advanced CKD updates. Scientific and dynamic format, and great engagement. Proud to lead this initiative — and ready for the next season starting in September.
🎙️https://www.senefro.org/modules.php?name=noticias&d_op=view&idnew=1673
Honored to have participated in the 62nd ERA Congress in Vienna, both learning and contributing.
📍 Presented the IBERIK+ study on hyperkalemia in Spain
Always a privilege to be part of spaces that promote evidence, dialogue, and better care for our patients.
@theisn.org @sinnefro.bsky.social
Grateful to co-author two studies with the Microbiology Dept. at Hospital Clínico Valencia — a great example of how collaboration leads to better evidence and outcomes.
🦠🧪
📄 pubmed.ncbi.nlm.nih.gov/40326950/
📄 pubmed.ncbi.nlm.nih.gov/40232234/
@amersocvirology.bsky.social @senefrologia.bsky.social
💔➡️🧂🛑
Proud to have contributed to this review on tackling renal sodium avidity in chronic HF.
📊 Includes a clear infographic — open access: pubmed.ncbi.nlm.nih.gov/40228493/
@secardiologia.bsky.social @senefrologia.bsky.social @nefrontera.bsky.social @sinnefro.bsky.social
Just read about the NUDGE-CKD trial: over 22K patients with chronic kidney disease are getting digital nudges to boost use of guideline-directed therapies. Simple idea, big potential. 📬💊 #CKD #DigitalHealth #Nudges
www.ahajournals.org/doi/epdf/10....
@kidney.org @senefrologia.bsky.social
🚀 RETOS EN NEFRITIS LÚPICA: el nuevo curso y concurso de #FormacionSenefro, el GdT JOVSEN, SEReumatología y JOVREUM
🏅Entérate de cómo aprender y ganar créditos o premios en este concurso de preguntas rápidas retosnefritislupica.com#/public/inicio
@drmontomoli.bsky.social
¡Inscripciones abiertas!
📢Ya puedes disfrutar del episodio 2⃣ de #ERCAnews:
▶️Canal @YouTube @SENefrologia
🎧@ivoox y @Spotify
🧠Transcripción JC
🔴Acceso a la presentación en PDF
📖Artículos
📍Todo en: senefro.org/modules.php?na… @sinnefro.bsky.social @senefrologia.bsky.social @theisn.org @nefrontera.bsky.social
Hay un error en el enlace ZOOM, actualizo: us02web.zoom.us/webinar/regi...
¡Llega el segundo ERCA News! Un proyecto formativo impulsado por los GdT de @senefrologia.bsky.social #ERCA y #senjoven.
Webinar 2⃣: 12 de mayo a las 17h (hora Madrid)
⏱️ En solo 30 minutos, comentamos 4-5 artículos clave sobre ERCA.
Inscripción gratuita aquí: us02web.zoom.us/webinar/regist…
⚠️ More common than cancer or diabetes
⚰️ Leading cause of premature death
💸 Huge cost: up to 4% of health budgets
❌ 98% lack access to dialysis in low-resource countries
♻️ Dialysis = high carbon footprint
🧠 Public awareness shockingly low
It's time to act.
nature.com/articles/s41581-024-00829-x
🎉 ¡Éxito rotundo del primer episodio!
Ya puedes disfrutarlo en las siguientes plataformas:
📺 YouTube
🎧 Spotify
📝 Transcripción de JC
📄 Artículos originales
Todo esto y más en el siguiente enlace:
👉 senefro.org/modules.php?name=noticias&d_op=view&idnew=1673
@senefrologia.bsky.social @theisn.org
🔬 Multicenter study across Spain validates the KFRE equation in patients with advanced CKD. The 4-variable version shows strong predictive value for dialysis progression, though recalibration is needed. 📊 #nephrology #CKD #KFRE
doi.org/10.1016/j.nefro.2025.02.004
@senefrologia.bsky.social
Prouder of having involved the Nephrology Department at Hospital Clínico de Valencia in reviewing the latest topics than of the result itself… What a fun way to quickly go over current issues! 🚀 @senefrologia.bsky.social @theisn.org @ajkd.bsky.social @secardiologia.bsky.social
¡Ya puedes inscribirte al primer webinar de ERCA News! 📚
🗓️ Lunes 14/04 | 🕔 17:00h | 🎙️ Partecipo
Revisión de artículos clave sobre ERCA en 30 min.
Avalado por @senefrologia.bsky.social, con la colaboración de Vifor y @novonordisk.bsky.social
🔗 Inscríbete aquí: us02web.zoom.us/webinar/regi...
🩸 Kidney Oxygen Sensing 🏥
The kidneys regulate EPO based on oxygen levels. In #CKD, impaired sensing leads to anemia. 🏗️ Proximal tubule hypoxia plays a key role, while #HIF and #SGLT2i therapies may restore EPO production. #RenalPhysiology #Anemia
academic.oup.com/ndt/article/...
@theisn.org
🧠💊 Major progress in MN! While current therapies (rituximab, steroids) work for many, 20–30% face resistance. 🔬 New hope: anti-CD20 (obinutuzumab), anti-CD38 (daratumumab), anti-complement (iptacopan) & even CAR-T! The future is precision medicine. 🚀
academic.oup.com/ckj/article/...
#nephrology
🔬 NT-proBNP & HF Risk in CKD ❤️ Standard NT-proBNP cut-off (125 pg/mL) misclassifies CKD patients. A study (18,261 pts) found eGFR-specific cut-offs improved risk prediction (NRI 19-55%). Adjusting for kidney function enhances HF assessment.
📖 heart.bmj.com/content/early/…
@isgd.bsky.social
A challenge and a test for nephrologists: optimizing the timing and sequencing of kidney protective therapies in CKD..
journals.lww.com/cjasn/fulltext…
aMR in the spectrum of cardiorenal diseases
💊 Spironolactone and eplerenone: For HFrEF or post-MI.
🩺 Finerenone: For CKD + T2D. Fewer hormonal side effects and stronger anti-inflammatory & anti-fibrotic effects.
⚠️ Consider renal function and risk of hyperkalemia.
academic.oup.com/ndt/article/...
🔬 New concept in nephrology: DMANDs (Disease-Modifying Anti-Nephropathic Drugs) are defined.
📌 Requirements:
✅ Reduce disease activity
✅ Prevent kidney damage
✅ Minimize toxicity
🚀 Goal: Improve treatments and avoid non-selective immunosuppressants.
academic.oup.com/ndt/advance-...
🔎 Un dato preocupante: la esperanza de vida sigue subiendo, pero los años con buena salud bajan 📉.
💡 La clave está en la prevención: más hábitos saludables, mejor atención primaria y entornos que fomenten el bienestar.
🔗 elpais.com/salud-y-bien...
#Prevención 💪 #HábitosSaludables 🚶♂️
💙 New on BlueSky! 💙
Deeply convinced that in life, you have to step strong. 🚀✨
Exploring, learning, and sharing insights on Nephrology and beyond.
📍 Nephrologist at H. Clinic Valencia
🔬 #MedEd | 🌍 #FOAMed
See you on BlueSky!
